Adhesion protect by an angiotensin type 1 receptor antagonist
Project/Area Number |
23791723
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Anesthesiology/Resuscitation studies
|
Research Institution | Wakayama Medical University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | カンデサルタン / PAI-1 / 糖尿病 / 開腹術 / 癒着 / 内蔵癒着 |
Research Abstract |
Adhesion formations are important causes of intestinal obstruction and can lead to infertility in women. This study indicated that angiotensin type 1receptorantagonist, candesartan, can reduce plasminogen activator inhibitor-1 mRNA expression using experimental model of peritoneal adhesions.
|
Report
(3 results)
Research Products
(2 results)
-
-
[Presentation] Ultrasound-guided Lateral Approach of the Infraclavicular Axillary Vein Catheterization May Have a Risk of Brachial Plexus Injury2011
Author(s)
Seiko Yoshimura, M.D., Keisuke Fujii, M.D., Masanori Haba, M.D., Takaaki Negoro, M.D., Koji Ogawa, M.D
Organizer
Annual Meeting of American Society of Anesthesiologists
Place of Presentation
Chicago, IL, USA
Related Report